Back to Search
JOSEF PRCHAL, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1427008341IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
L3441(TX)6126495-1205(UT)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
L3441(TX)6126495-1205(UT)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
L3441(TX)
Education
OTHER
Class of 1968
Research & Publications (20)
Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001.
PMID 19484334·Int J Hematol·2009
3-trial
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691.
PMID 19626540·Leuk Lymphoma·2009
3-trial
Nonmyristoylated matrix protein from the Mason-Pfizer monkey virus forms oligomers.
PMID 19481092·J Mol Biol·2009
8-other
The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.
PMID 19440215·Leukemia·2009
8-other
Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.
PMID 19135773·Exp Hematol·2009
8-other
Enrichment of Sca1+ hematopoietic progenitors in polycythemic mice inhibits leukemogenesis.
PMID 19584401·Blood·2009
7-preclinical
Plasma quantitation of JAK2 mutation is not suitable as a clinical test: an artifact of storage.
PMID 19574481·Blood·2009
4-observational
Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms.
PMID 19615425·Exp Hematol·2009
8-other
Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.
PMID 19001280·Haematologica·2009
4-observational
Essential role for Nix in autophagic maturation of erythroid cells.
PMID 18454133·Nature·2008
7-preclinical
The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation.
PMID 18482053·Cancer Sci·2008
7-preclinical
Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia.
PMID 18729851·Br J Haematol·2008
8-other
Philadelphia chromosome-negative myeloproliferative disorders: an historical perspective.
PMID 19074060·Hematology Am Soc Hematol Educ Program·2008
7-preclinical
Elevated homocysteine, glutathione and cysteinylglycine concentrations in patients homozygous for the Chuvash polycythemia VHL mutation.
PMID 18223282·Haematologica·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1950 CIRCLE OF HOPE DR
SALT LAKE CITY, UT 84112 - Phone
- (801) 585-0100
Quick Facts
- NPI
- 1427008341
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 5
- Locations
- 1
- Years in Practice
- 58
- Publications
- 20
Are you this provider?
Claim Your Profile